| Aug 12 |
Earnings summary: Esperion Therapeutics reports mixed Q2 results; reaffirms FY24 outlook
|
| Aug 12 |
Esperion Therapeutics: Q2 Earnings Snapshot
|
| Aug 12 |
Esperion Therapeutics GAAP EPS of -$0.33 misses by $0.16, revenue of $73.83M beats by $24.77M
|
| Aug 12 |
Esperion Reports Second Quarter 2024 Financial Results and Provides a Business Update
|
| Aug 12 |
Biggest stock movers today: KEY, HUMA, and more
|
| Aug 9 |
Esperion Therapeutics Q2 2024 Earnings Preview
|
| Aug 7 |
Assertio (ASRT) Reports Q2 Loss, Tops Revenue Estimates
|
| Jul 25 |
Esperion to Report Second Quarter 2024 Financial Results on August 12
|
| Jul 24 |
Esperion to Participate in Upcoming BTIG Biotech Conference
|
| Jul 22 |
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
|
